Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
61.63B
Market cap61.63B
Price-Earnings ratio
62.40
Price-Earnings ratio62.40
Dividend yield
—
Dividend yield—
Average volume
6.37M
Average volume6.37M
High today
$107.69
High today$107.69
Low today
$106.01
Low today$106.01
Open price
$106.11
Open price$106.11
Volume
3.82M
Volume3.82M
52 Week high
$107.69
52 Week high$107.69
52 Week low
$74.66
52 Week low$74.66

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $106.50, with a market capitalization of 61.63B. The stock trades at a price-to-earnings (P/E) ratio of 62.40.

During the trading session on 2026-11-14, Edwards Lifesciences(EW) shares reached a daily high of $107.69 and a low of $106.01. At a current price of $106.50, the stock is +0.5% higher than the low and still -1.1% under the high.

Trading activity shows a volume of 3.82M, compared to an average daily volume of 6.37M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $107.69 and a low of $74.66.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $107.69 and a low of $74.66.

EW News

Simply Wall St 22h
Is Edwards Lifesciences Fully Priced On Raised Guidance And Clinical Trial Wins?

Edwards Lifesciences (EW) just reported a third quarter earnings update showing higher year on year sales and net income, along with raised full year 2026 guida...

Is Edwards Lifesciences Fully Priced On Raised Guidance And Clinical Trial Wins?
TipRanks 1d
Edwards Updates ECLIPTIS Heart Device Study: What EW Investors Should Know

Edwards Lifesciences Corp. (EW) announced an update on their ongoing clinical study. Study Overview: Edwards Lifesciences (NYSE: EW) updated the CLAARITY study...

Simply Wall St 6d
What Edwards Lifesciences Stock Beat And Raised Outlook Means For Shareholders

Edwards Lifesciences reported third quarter 2026 sales of US$1,715.5 million and net income of US$307.5 million, and raised full year guidance for total sales g...

What Edwards Lifesciences Stock Beat And Raised Outlook Means For Shareholders

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
16.1%
Sell
3.2%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.